Lu Zenghong, Zhu Gangfeng, Feng Xiaofei, Xiang Yi, Chen Cixiang, Yuan Huiting, Chen Zhixing
Department of Oncology, The First Affiliated Hospital, Gannan Medical University, Ganzhou, China.
First Clinical Medical College, Gannan Medical University, Ganzhou, China.
Front Genet. 2024 Nov 27;15:1435132. doi: 10.3389/fgene.2024.1435132. eCollection 2024.
Cervical cancer remains a significant challenge in oncology with an escalating demand for novel therapeutic strategies that can navigate the complexities of its pathophysiology. This study elucidated the antineoplastic effects of cryptotanshinone, a derivative of danshen (), a herb widely utilized in traditional Chinese medicine practices.
Employing a comprehensive multi-omics approach, including transcriptomic, proteomic, and bioinformatics analyses, we investigated the potential effects of cryptotanshinone on cervical cancer through data mining and computational analysis.
Our results demonstrated that the potential of cryptotanshinone to disrupted cancer cell proliferation and induced apoptosis may be ascribed to its modulation of gene expression and interaction with specific protein networks. Furthermore, network pharmacology and pathway enrichment analyses identified critical hubs and signaling pathways, suggesting a multi-targeted mechanism of action. Furthermore, the establishment of a prognostic model, which is founded upon differentially expressed genes linked to cryptotanshinone treatment, underscores its promising role as both a prognostic biomarker and a therapeutic agent. These insights pave the way for the integration of cryptotanshinone into therapeutic regimens, offering a promising avenue for enhancing the efficacy of cervical cancer treatment and patient outcomes.
宫颈癌仍然是肿瘤学领域的一项重大挑战,对于能够应对其复杂病理生理学的新型治疗策略的需求不断增加。本研究阐明了隐丹参酮的抗肿瘤作用,隐丹参酮是丹参的一种衍生物,丹参是一种在传统中医实践中广泛使用的草药。
我们采用了一种全面的多组学方法,包括转录组学、蛋白质组学和生物信息学分析,通过数据挖掘和计算分析研究了隐丹参酮对宫颈癌的潜在影响。
我们的结果表明,隐丹参酮破坏癌细胞增殖和诱导凋亡的潜力可能归因于其对基因表达的调节以及与特定蛋白质网络的相互作用。此外,网络药理学和通路富集分析确定了关键节点和信号通路,表明其具有多靶点作用机制。此外,基于与隐丹参酮治疗相关的差异表达基因建立的预后模型,强调了其作为预后生物标志物和治疗剂的潜在作用。这些见解为将隐丹参酮纳入治疗方案铺平了道路,为提高宫颈癌治疗效果和患者预后提供了一条有前景的途径。